Company · CIK 0001125345 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
MACROGENICS INC · MGNX
Insider activity reported against this company. All insider holders · Files at: PRVB. On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 3, 2015 MForm 4 → | Aug 3, 2:47 pm EDT | Jon Marc WiggintonSr VP, Clinical | 10,000 | $4.70 | $47,000 | 10,000 | — | plan? amended |
| Jul 10, 2015 SForm 4 → | Jul 13, 3:23 pm EDT | Ezio BonviniSenior VP, Research | 2,400 | $38.09 | $91,416 | 36,790 | −6.12% | plan? |
| Jul 10, 2015 MForm 4 → | Jul 13, 3:23 pm EDT | Ezio BonviniSenior VP, Research | 2,400 | $0.71 | $1,704 | 39,190 | — | plan? |
| Jul 1, 2015 MForm 4 → | Nov 24, 3:32 pm EST | Lynn CilinskiVP, Controller and Treasurer | 5,000 | $0.94 | $4,700 | 7,659 | — | plan? late |
| Jul 1, 2015 SForm 4 → | Jul 1, 4:28 pm EDT | Lynn CilinskiVP, Controller and Treasurer | 6,921 | $37.15 | $257,115 | 3,844 | −64.3% | plan? |
| Jul 1, 2015 MForm 4 → | Jul 1, 4:28 pm EDT | Lynn CilinskiVP, Controller and Treasurer | 5,000 | $0.94 | $4,700 | 10,765 | — | plan? |
| Jul 1, 2015 SForm 4 → | Jul 1, 4:28 pm EDT | Jon Marc WiggintonSr VP, Clinical | 5,000 | $37.15 | $185,750 | 0 | −100% | plan? |
| Jul 1, 2015 MForm 4 → | Jul 1, 4:28 pm EDT | Jon Marc WiggintonSr VP, Clinical | 5,000 | $4.70 | $23,500 | 5,000 | — | plan? |
| Jun 30, 2015 SForm 4 → | Jul 1, 4:27 pm EDT | Ezio BonviniSenior VP, Research | 6,497 | $38.07 | $247,341 | 36,790 | −15.0% | plan? |
| Jun 30, 2015 MForm 4 → | Jul 1, 4:27 pm EDT | Ezio BonviniSenior VP, Research | 6,497 | $0.71 | $4,613 | 43,287 | — | plan? |
| Jun 24, 2015 SForm 4/A → | Jul 1, 4:27 pm EDT | Ezio BonviniSenior VP, Research | 6,097 | $38.08 | $232,174 | 36,790 | −14.2% | plan? |
| Jun 24, 2015 MForm 4/A → | Jul 1, 4:27 pm EDT | Ezio BonviniSenior VP, Research | 6,097 | $0.71 | $4,329 | 42,887 | — | plan? |
| Jun 24, 2015 SForm 4 → | Jun 25, 3:39 pm EDT | Ezio BonviniSenior VP, Research | 6,097 | $38.08 | $232,174 | 17,639 | −25.7% | plan? amended |
| Jun 23, 2015 SForm 4/A → | Jul 1, 4:27 pm EDT | Ezio BonviniSenior VP, Research | 13,054 | $38.14 | $497,880 | 36,790 | −26.2% | plan? |
| Jun 23, 2015 MForm 4/A → | Jul 1, 4:27 pm EDT | Ezio BonviniSenior VP, Research | 13,054 | $0.71 | $9,268 | 49,844 | — | plan? |
| Jun 23, 2015 SForm 4 → | Jun 24, 3:07 pm EDT | Ezio BonviniSenior VP, Research | 13,054 | $38.14 | $497,880 | 23,736 | −35.5% | plan? amended |
| Jun 15, 2015 SForm 4 → | Jun 16, 1:28 pm EDT | Lynn CilinskiVP, Controller and Treasurer | 10,700 | $35.00 | $374,500 | 5,765 | −65.0% | plan? |
| Jun 15, 2015 MForm 4 → | Jun 16, 1:28 pm EDT | Lynn CilinskiVP, Controller and Treasurer | 5,000 | $0.94 | $4,700 | 16,465 | — | plan? |
| Jun 15, 2015 SForm 4 → | Jun 16, 1:28 pm EDT | Ezio BonviniSenior VP, Research | 6,233 | $34.01 | $211,984 | 36,790 | −14.5% | plan? |
| Jun 15, 2015 MForm 4 → | Jun 16, 1:28 pm EDT | Ezio BonviniSenior VP, Research | 6,233 | $0.71 | $4,425 | 43,023 | — | plan? |
| May 15, 2015 SForm 4 → | May 18, 4:15 pm EDT | Ezio BonviniSenior VP, Research | 6,233 | $30.24 | $188,486 | 36,790 | −14.5% | plan? |
| May 15, 2015 MForm 4 → | May 18, 4:15 pm EDT | Ezio BonviniSenior VP, Research | 6,233 | $0.71 | $4,425 | 43,023 | — | plan? |
| May 11, 2015 JForm 4 → | May 13, 1:56 pm EDT | Edward HurwitzDirector | 18,074 | — | — | 18,074 | — | plan? |
| Apr 28, 2015 FForm 4 → | Apr 29, 2:32 pm EDT | Atul SaranGeneral Counsel | 925 | $32.02 | $29,619 | 20,710 | — | plan? |
| Apr 15, 2015 SForm 4 → | Apr 16, 11:12 am EDT | Ezio BonviniSenior VP, Research | 6,233 | $33.98 | $211,797 | 36,790 | −14.5% | plan? |
| Apr 15, 2015 MForm 4 → | Apr 16, 11:12 am EDT | Ezio BonviniSenior VP, Research | 6,233 | $0.71 | $4,425 | 43,023 | — | plan? |
| Apr 1, 2015 SForm 4 → | Apr 3, 7:57 am EDT | Jon Marc WiggintonSr VP, Clinical | 5,000 | $30.86 | $154,300 | 0 | −100% | plan? |
| Feb 2, 2015 SForm 4 → | Feb 3, 2:58 pm EST | Jon Marc WiggintonSr VP, Clinical | 5,000 | $31.04 | $155,200 | 0 | −100% | plan? |
| Feb 2, 2015 MForm 4 → | Feb 3, 2:58 pm EST | Jon Marc WiggintonSr VP, Clinical | 5,000 | $4.70 | $23,500 | 5,000 | — | plan? |
| Apr 1, 2014 MForm 4 → | Apr 3, 2015, 7:57 am EDT | Jon Marc WiggintonSr VP, Clinical | 5,000 | $4.70 | $23,500 | 5,000 | — | plan? late |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 18, 2015 AForm 4 → | Dec 22, 1:13 pm EST | Scott KoenigPresident and CEO, Director | 150,000 | — | — | 150,000 | — | |
| Dec 18, 2015 AForm 4 → | Dec 22, 1:13 pm EST | James KarrelsSVP, CFO and Secretary | 45,000 | — | — | 45,000 | — | |
| Dec 18, 2015 AForm 4 → | Dec 22, 1:12 pm EST | Lynn CilinskiVP, Controller and Treasurer | 22,000 | — | — | 22,000 | — | |
| Dec 18, 2015 AForm 4 → | Dec 22, 1:11 pm EST | Ezio BonviniSenior VP, Research | 55,000 | — | — | 55,000 | — | |
| Nov 23, 2015 MForm 4 → | Nov 24, 3:32 pm EST | Lynn CilinskiVP, Controller and Treasurer | 5,000 | — | — | 9,501 | — | |
| Oct 13, 2015 MForm 4 → | Oct 15, 2:37 pm EDT | Ezio BonviniSenior VP, Research | 14,521 | — | — | 0 | — | |
| Oct 7, 2015 MForm 4 → | Oct 9, 9:52 am EDT | James KarrelsSVP, CFO and Secretary | 6,000 | — | — | 16,533 | — | |
| Oct 2, 2015 MForm 4 → | Oct 6, 2:19 pm EDT | Ezio BonviniSenior VP, Research | 17,877 | — | — | 0 | — | |
| Oct 1, 2015 MForm 4/A → | Oct 7, 4:08 pm EDT | Jon Marc WiggintonSr VP, Clinical | 5,000 | — | — | 45,194 | — | |
| Oct 1, 2015 MForm 4 → | Oct 2, 4:22 pm EDT | Jon Marc WiggintonSr VP, Clinical | 5,000 | — | — | 45,194 | — | amended |
| Sep 18, 2015 MForm 4 → | Sep 22, 3:19 pm EDT | Ezio BonviniSenior VP, Research | 7,000 | — | — | 5,893 | — | |
| Sep 16, 2015 MForm 4 → | Sep 18, 10:33 am EDT | Ezio BonviniSenior VP, Research | 4,000 | — | — | 12,893 | — | |
| Aug 26, 2015 MForm 4 → | Aug 28, 11:30 am EDT | Ezio BonviniSenior VP, Research | 10,000 | — | — | 16,893 | — | |
| Aug 10, 2015 MForm 4 → | Aug 11, 8:41 am EDT | Ezio BonviniSenior VP, Research | 4,000 | — | — | 26,893 | — | |
| Aug 3, 2015 MForm 4/A → | Oct 7, 4:07 pm EDT | Jon Marc WiggintonSr VP, Clinical | 10,000 | — | — | 50,194 | — | |
| Aug 3, 2015 MForm 4 → | Aug 3, 2:47 pm EDT | Jon Marc WiggintonSr VP, Clinical | 10,000 | — | — | 50,194 | — | amended |
| Jul 10, 2015 MForm 4 → | Jul 13, 3:23 pm EDT | Ezio BonviniSenior VP, Research | 2,400 | — | — | 14,521 | — | |
| Jul 1, 2015 MForm 4 → | Jul 1, 4:28 pm EDT | Lynn CilinskiVP, Controller and Treasurer | 5,000 | — | — | 1,185 | — | |
| Jul 1, 2015 MForm 4 → | Jul 1, 4:28 pm EDT | Jon Marc WiggintonSr VP, Clinical | 5,000 | — | — | 60,194 | — | |
| Jun 30, 2015 MForm 4 → | Jul 1, 4:27 pm EDT | Ezio BonviniSenior VP, Research | 6,497 | — | — | 16,921 | — | |
| Jun 24, 2015 MForm 4/A → | Jul 1, 4:27 pm EDT | Ezio BonviniSenior VP, Research | 6,097 | — | — | 23,418 | — | |
| Jun 23, 2015 MForm 4/A → | Jul 1, 4:27 pm EDT | Ezio BonviniSenior VP, Research | 13,054 | — | — | 29,515 | — | |
| Jun 15, 2015 MForm 4 → | Jun 16, 1:28 pm EDT | Lynn CilinskiVP, Controller and Treasurer | 5,000 | — | — | 6,185 | — | |
| Jun 15, 2015 MForm 4 → | Jun 16, 1:28 pm EDT | Ezio BonviniSenior VP, Research | 6,233 | — | — | 42,569 | — | |
| May 20, 2015 AForm 4 → | May 21, 2:31 pm EDT | David C StumpDirector | 8,500 | — | — | 8,500 | — | |
| May 20, 2015 AForm 4 → | May 21, 2:31 pm EDT | Edward HurwitzDirector | 8,500 | — | — | 8,500 | — | |
| May 20, 2015 AForm 4 → | May 21, 2:30 pm EDT | Kenneth GalbraithDirector | 8,500 | — | — | 8,500 | — | |
| May 20, 2015 AForm 4 → | May 21, 2:30 pm EDT | Matthew K FustDirector | 8,500 | — | — | 8,500 | — | |
| May 20, 2015 AForm 4 → | May 21, 2:29 pm EDT | Paulo F CostaDirector | 11,813 | — | — | 3,313 | — | |
| May 15, 2015 MForm 4 → | May 18, 4:15 pm EDT | Ezio BonviniSenior VP, Research | 6,233 | — | — | 48,802 | — | |
| Apr 15, 2015 MForm 4 → | Apr 16, 11:12 am EDT | Ezio BonviniSenior VP, Research | 6,233 | — | — | 55,035 | — | |
| Apr 1, 2015 MForm 4 → | Apr 3, 7:57 am EDT | Jon Marc WiggintonSr VP, Clinical | 5,000 | — | — | 65,194 | — | |
| Feb 2, 2015 MForm 4 → | Feb 3, 2:58 pm EST | Jon Marc WiggintonSr VP, Clinical | 5,000 | — | — | 70,194 | — |
Filed by this entity as an insider elsewhere — common stock
No reported common-stock activity in this period.
Filed by this entity as an insider elsewhere — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.